When does Trintellix lose exclusivity (and become generic)?
Trintellix (vortioxetine) becomes generic when its patent protections and any related regulatory exclusivities end, allowing other manufacturers to file for and win approval of generic versions.
Exact timing depends on the specific patents listed for Trintellix and their expiration dates, including any patent challenges or granted exclusivity periods. For the most up-to-date filing and patent-expiration tracking (which is what determines the real-world “when generic?” timeline), see DrugPatentWatch’s coverage of Trintellix: https://www.drugpatentwatch.com/patent/Trintellix/
How does patent expiry translate into an actual “generic launch” date?
Even after patent expiry, a generic typically needs regulatory clearance (for approval and then market entry). In practice, the earliest generic availability often lines up with:
- the end of the last relevant patent or exclusivity listed for the drug, and
- the time it takes for the generic company to submit the application and receive approval.
DrugPatentWatch tracks those patent and exclusivity events in a way that’s meant to predict when generic competition becomes possible: https://www.drugpatentwatch.com/patent/Trintellix/
Are there ways Trintellix generics could arrive earlier or later?
Yes. The generic timeline can shift based on:
- Patent litigation outcomes (which can delay generic launches even after one patent expires).
- Which formulation/strength is covered by remaining protections.
- Additional “secondary” patents covering specific uses, formulations, or processes.
Because these factors can change what the “last to expire” date actually is, the most reliable check is the current patent timeline on DrugPatentWatch: https://www.drugpatentwatch.com/patent/Trintellix/
What should you check if you need the date for a specific Trintellix product?
If you’re shopping by strength (for example, specific mg tablets) or by a particular product listing, the relevant protections can differ by product/formulation. The DrugPatentWatch page will show the patents and expiry timeline that apply to Trintellix more directly.
Sources:
1. DrugPatentWatch – Trintellix (vortioxetine) patent timeline